Skip to Content

CL 26 (Montelukast Sodium 10 mg (base))

Pill with imprint CL 26 is Beige, Four-sided and has been identified as Montelukast Sodium 10 mg (base). It is supplied by Macleods Pharmaceuticals Limited.

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 26

Montelukast sodium 10 mg (base) CL 26

Montelukast Sodium

Imprint
CL 26
Strength
10 mg (base)
Color
Beige
Shape
Four-sided
Availability
Prescription only
Drug Class
Leukotriene modifiers
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0102

Get help with Imprint Code FAQs.

Related Images for "CL 26"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.